About
Secretome Therapeutics develops scalable neonatal cell-based therapies targeting heart failure and dilated cardiomyopathy by leveraging neonatal cardiac progenitor cells with high potency and consistency.
Explore Secretome Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.